CM
REGN icon

Caption Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Caption Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,200
Closed -$17.6M – 1978
2025
Q2 		$16.4M Buy
+31,200
New +$17.4M 0.18% 117
2024
Q4 		– Sell
-900
Closed -$946K – 1774
2024
Q3 		$946K Buy
+900
New +$1M 0.02% 791
2023
Q4 		– Sell
-12,000
Closed -$9.88M – 1610
2023
Q3 		$9.88M Buy
+12,000
New +$9.43M 0.15% 161
2021
Q1 		– Sell
-4,000
Closed -$1.93M – 1328
2020
Q4 		$1.93M Buy
+4,000
New +$2.16M 0.04% 444
2019
Q3 		– Sell
-1,500
Closed -$469K – 863
2019
Q2 		$469K Buy
+1,500
New +$499K 0.02% 490

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Caption Management's REGN Position: Q3 2025 in Review

Caption Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 31,200 shares — an estimated $17.6M sold.

Caption Management first reported a position in REGN in Q2 2019 and held it in 5 quarters. The position peaked at $16.4M in Q2 2025. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Caption Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 31,200 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $17.6M.
  • Caption Management first reported a position in Regeneron Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Caption Management's Regeneron Pharmaceuticals position peaked at $16.4M in Q2 2025.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.